The K-562 genome is characterized by the presence of the BCR-ABL1 fusion gene, which serves as a crucial molecular marker in the diagnosis and treatment of CML in clinical practice26. Here, ABL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.